Brokerages Set Cara Therapeutics, Inc. (NASDAQ:CARA) PT at $83.52
Shares of Cara Therapeutics, Inc. (NASDAQ:CARA – Get Free Report) have earned a consensus recommendation of “Hold” from the five brokerages that are presently covering the stock, MarketBeat reports. Five investment analysts have rated the stock with a hold rating. The average 12-month target price among analysts that have covered the stock in the last […]
Shares of Cara Therapeutics, Inc. (NASDAQ:CARA – Get Free Report) have earned a consensus recommendation of “Hold” from the five brokerages that are presently covering the stock, MarketBeat reports. Five investment analysts have rated the stock with a hold rating. The average 12-month target price among analysts that have covered the stock in the last […]
